Introduction
The Therapeutic Goods Administration refers to complementary medicines as 'medicinal products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, traditional medicines and certain aromatherapy products'. 1 In Australia, complementary medicines are largely regulated as unscheduled medicines, and are usually self-selected.
Complementary medicines are very popular among Australians, with surveys indicating that up to 60% of people use at least one complementary medicine on a regular basis. However, about 50% of consumers also report using a conventional medicine on the same day as their complementary medicine. 2, 3 It is not surprising, therefore, that healthcare professionals and consumers alike are concerned about the potential for drug interactions between these medicines.
As so many Australians use complementary medicines, including children, the elderly, patients with chronic disease, mental health disorders and cancer, it is important that prescribers always ask what complementary products their patients are taking in addition to any conventional medicines. Knowing this, and extrapolating reported pharmacodynamic and pharmacokinetic outcomes, can help predict potential drug interactions.
Polypharmacy
Complementary medicines are frequently used in the context of polypharmacy. A study of 3070 elderly people found that 74.2% took at least one prescription drug and one complementary medicine, with 32.5% of them using three or more prescription medicines with three or more complementary medicines. 4 This translates to an increased risk of drug interactions. In a study of 458 US Veterans' Administration patients, 197 of them reported taking complementary medicines combined with prescription medicines. Of these patients, 45% had potential for interactions, which was rated as serious in 6% of patients. 5 In another study which interviewed 3000 people (aged 57−85) about prescription, over-the-counter and complementary medicine use, 4% of them were potentially at risk of a major drug-drug interaction. 6 It has been suggested that once a patient is on eight or more medicines, regardless of origin, there is a 100% chance of a drug interaction occurring. 7 
Drug interactions
As with other drugs, complementary medicine interactions Due to their complex chemical structure, herbal medicines are prone to interactions via the oxidative cytochrome P450 system or the efflux drug transporter P-glycoprotein. 8, 9 In vitro assays, using human tissue or cell lines, are frequently used to determine whether a herb affects these enzymes. 10 www.australianprescriber.com are used concomitantly. 9 A classic example is St John's wort, which has kinetic interactions with a wide range of drugs via the induction of CYP1A2, CYP3A4, CYP2C9 and P-glycoprotein. 11 This lowers the concentration of the concomitant drug. 
Table 1
Evidence-based complementary medicine interactions 8, 11, 13, 14 This 11 The level of severity (major, moderate, minor) has been calculated using the evidence and probability of harm. This rating is linked with a generic recommendation for management.
Major
Strongly discourage patients from using this combination as a serious adverse outcome could occur. If used, patient should be monitored closely for potential adverse outcomes.
Moderate Use cautiously or avoid combination as a significant adverse outcome could occur. If used, monitor for potential adverse outcomes.
Minor
Be aware that there is a chance of an interaction. Advise patients of symptoms that may occur and an action plan to follow.
Level of evidence ratings:
A High-quality randomised controlled trial or meta-analysis Specific criteria were used to identify 52 resources -26 of these ... Table continued were shortlisted and assessed for technical quality, content and clinical utility. The quality of drug interaction information was also assessed in the review, specifically whether mechanisms were outlined, degree of severity was stated, and whether the absence of known drug interactions was disclosed.
While many resources (free or subscription) had technical strengths, few had comprehensive interaction coverage.
Those with some detail are included for further reading. Two of the highest ranked resources were online subscription databases, both of which contained reasonably comprehensive complementary medicine-drug interaction checkers. These were:
n Natural Standard (www.naturalstandard.com), which provides detailed monographs and brief summaries ('bottom line') n Natural Medicines Comprehensive Database (www.naturaldatabase.com).
Conclusion
Consumers frequently use complementary medicines in combination with conventional medicines. For this reason, health professionals should always consider the potential for pharmacodynamic and pharmacokinetic interactions between them. High quality evidence is increasingly available for identification and prevention of these interactions.
